France· FR:61696661
CLARISCAN 0,5 mmol/mL, solution injectable
A medicinal product containing gadotérate de méglumine, registered in France by GE HEALTHCARE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- GADOTÉRATE DE MÉGLUMINE
- Manufacturer
- GE HEALTHCARE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 8
- cip13340093009195110 flacon(s) en verre de 20 ml
- cip13340093009189010 flacon(s) en verre de 5 ml
- cip1334009300919061 flacon(s) en verre de 10 ml
- cip13340093009191310 flacon(s) en verre de 10 ml
- cip1334009300919201 flacon(s) en verre de 15 ml
- cip13340093009193710 flacon(s) en verre de 15 ml
- cip1334009300919441 flacon(s) en verre de 20 ml
- cip13340093009199910 bouteille(s) polypropylène de 50 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadotérate de méglumine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCLARISCANGE Healthcare AS, Oslo
- BelgiumClariscan 0.5 mmol/mlGE Healthcare
- United StatesCLARISCANGE Healthcare
- CanadaDOTAREMGUERBET
- GermanyArtiremGuerbet
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Dotarem
- Germany · Artirem
- Spain · Dotarem
- Portugal · Dotarem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/68a44da9-16d9-4cca-8392-ca88b436fc7d GET /v1/drugs/68a44da9-16d9-4cca-8392-ca88b436fc7d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61696661",
"date_amm": "2017-05-09",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "GADOTÉRATE DE MÉGLUMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about gadotérate de méglumine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.